Literature DB >> 26631273

Assemblages, territories, contexts.

Cameron Duff1.   

Abstract

Human geographers have been at the forefront of efforts across the social sciences to develop "assemblage thinking", applying and extending this model in a series of highly original empirical studies. This commentary assesses some of the conceptual, methodological and procedural implications of this research for contemporary drug studies. I will argue that the most useful way of approaching assemblage thinking in the analysis of drug problems is to focus on the ways assemblages draw together social, affective and material forces and entities. I will briefly review these three nodes before indicating how their analysis may inspire novel empirical assessments of drug assemblages. I will conclude by exploring how the assemblage may replace the 'subject' and 'social context' as a discrete unit of analysis in drug studies.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Affective geographies; Assemblage; Context; Deleuze; Drugs

Mesh:

Year:  2015        PMID: 26631273     DOI: 10.1016/j.drugpo.2015.10.003

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  4 in total

1.  Ontological journeys: The lifeworld of opium across the Afghan-Iranian border in/out of the pharmacy.

Authors:  Maziyar Ghiabi
Journal:  Int J Drug Policy       Date:  2021-01-21

2.  Therapeutic Environments in Drug Treatment: From Stigmatising Spaces to Enabling Places. A Theory-Based Qualitative Analysis.

Authors:  Mads Bank; Kirsten K Roessler
Journal:  Int J Environ Res Public Health       Date:  2022-04-20       Impact factor: 4.614

3.  Therapy without a prescription: buprenorphine/naloxone diversion and the therapeutic assemblage in Taiwan.

Authors:  Jia-Shin Chen
Journal:  Sociol Health Illn       Date:  2019-12-13

4.  Becoming Safe, Legal, Mature, Moderate, and Self-Reflexive: Trajectories of Drinking and Abstinence among Young People.

Authors:  Eva Samuelsson; Jukka Törrönen; Josefin Månsson; Filip Roumeliotis
Journal:  Int J Environ Res Public Health       Date:  2022-03-17       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.